Cerus Corp. Company Profile (NASDAQ:CERS)

About Cerus Corp.

Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company's INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The Company's INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, including human immunodeficiency virus (HIV), West Nile, Severe acute respiratory syndrome (SARS), hepatitis B and C; bacteria and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma and red blood cell transfusion products. The Company's INTERCEPT Blood System is for use with blood components, including plasma, platelets, and red blood cells.

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: Health Care Supplies
Exchange: NASDAQ
Symbol: CERS
CUSIP: 15708510

Key Metrics:

Previous Close: $6.23
50 Day Moving Average: $6.50
200 Day Moving Average: $6.21
52-Week Range: $4.27 - $7.64
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -10.68
P/E Growth: 0.00
Market Cap: $647.07M
Outstanding Shares: 102,709,000
Beta: 1.78

Profitability:

Net Margins: -189.29%
Return on Equity: -73.14%
Return on Assets: -48.73%

Debt:

Debt-to-Equity Ratio: 0.18%
Current Ratio: 4.36%
Quick Ratio: 3.89%

Additional Links:

Companies Related to Cerus Corp.:

Consensus Ratings for Cerus Corp. (NASDAQ:CERS) (?)

Ratings Breakdown:	1 Hold Rating, 6 Buy Ratings
Consensus Rating:	Buy (Score: 2.86)
Consensus Price Target:	$9.10 (44.44% upside)

Analysts' Ratings History for Cerus Corp. (NASDAQ:CERS)

Show:

Date	Firm	Action	Rating	Price Target
9/7/2016	FBR & Co	Reiterated Rating	Outperform	$10.00
8/6/2016	Robert W. Baird	Set Price Target	Buy	$9.00 -> $10.00
7/31/2016	Cantor Fitzgerald	Reiterated Rating	Buy	$9.00
6/20/2016	BTIG Research	Reiterated Rating	Buy	$10.00
2/6/2016	Stephens	Reiterated Rating	Buy
1/29/2016	Cowen and Company	Reiterated Rating	Buy
12/17/2015	Wedbush	Downgrade	Outperform -> Neutral	$6.50
6/30/2015	MLV & Co.	Reiterated Rating	Buy	$10.00

(Data available from 9/27/2014 forward)

Earnings History for Cerus Corp. (NASDAQ:CERS)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/3/2016
8/4/2016	Q216	($0.17)	($0.18)	$8.88 million	$9.25 million	View	N/A
5/3/2016	Q1	($0.16)	($0.17)	$8.29 million	$7.60 million	View	N/A
3/8/2016	Q415	($0.16)	($0.15)	$9.72 million	$9.70 million	View	Listen
11/5/2015	Q315	($0.16)	($0.17)	$10.00 million	$8.04 million	View	N/A
8/6/2015	Q215	($0.15)	($0.17)	$8.71 million	$8.83 million	View	N/A
5/5/2015	Q214	($0.16)	($0.17)	$7.70 million	$7.70 million	View	N/A
2/26/2015	Q114	($0.15)	($0.25)	$10.36 million	$9.70 million	View	N/A
11/4/2014	Q413	($0.13)	($0.15)	$9.83 million	$10.36 million	View	N/A
7/31/2014	Q313	($0.13)	($0.16)	$8.17 million	$8.60 million	View	N/A
5/1/2014	Q313	($0.12)	($0.12)	$9.65 million	$7.86 million	View	N/A
2/25/2014	Q213	($0.09)	($0.10)	$11.77 million	$9.23 million	View	N/A
10/29/2013		($0.09)	($0.29)	$10.34 million	$10.54 million	View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Cerus Corp. (NASDAQ:CERS)

Current Year EPS Consensus Estimate: $-0.67 EPS
Next Year EPS Consensus Estimate: $-0.59 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	($0.17)	($0.17)	($0.17)
Q2 2016	1	($0.16)	($0.16)	($0.16)
Q3 2016	1	($0.16)	($0.16)	($0.16)
Q4 2016	1	($0.16)	($0.16)	($0.16)

(Data provided by Zacks Investment Research)

Dividend History for Cerus Corp. (NASDAQ:CERS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Cerus Corp. (NASDAQ:CERS)

Insider Ownership Percentage: 6.60%
Institutional Ownership Percentage: 67.01%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/22/2016	Kevin Dennis Green	CFO	Sell	17,150	$6.80	$116,620.00
8/19/2015	Laurence M Corash	Insider	Buy	25,900	$4.99	$129,241.00
8/18/2015	Laurence M Corash	Insider	Buy	84,600	$4.77	$403,542.00
11/10/2014	William Mariner Greenman	CEO	Buy	21,800	$3.93	$85,674.00
11/19/2012	William Mariner Greenman	CEO	Buy	3,200	$3.02	$9,664.00
11/16/2012	Laurence M Corash	Insider	Buy	2,000	$2.85	$5,700.00
11/16/2012	William Mariner Greenman	CEO	Buy	13,800	$2.85	$39,330.00

(Data available from 1/1/2013 forward)

Latest Headlines for Cerus Corp. (NASDAQ:CERS)

Date	Headline
	First Week of May 2017 Options Trading For Cerus (CERS) (NASDAQ:CERS) www.stockoptionschannel.com - September 22 at 4:21 PM
	Mover To Watch: Cerus Corporation (NASDAQ:CERS) , Destination ... - Wall Street Times (press release) (NASDAQ:CERS) www.wallstreetnews24.com - September 21 at 4:48 PM
	Intraday Active Biotech Stocks News: Cerus Corporation (NASDAQ:CERS), INSYS Therapeutics, Inc. (NASDAQ:INSY) - The Voice Registrar (NASDAQ:CERS) voiceregistrar.com - September 15 at 4:31 PM
	How this East Bay company is helping squash Zika (NASDAQ:CERS) www.bizjournals.com - September 13 at 8:59 AM
	Hot Biotech Stocks Recap: Geron Corporation (NASDAQ:GERN), Cerus Corporation (NASDAQ:CERS) - The Voice Registrar (NASDAQ:CERS) voiceregistrar.com - September 12 at 4:01 PM
	Biotech news that matter for investors: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Cerus Corporation (NASDAQ:CERS) - The Voice Registrar (NASDAQ:CERS) voiceregistrar.com - September 9 at 8:59 AM
	Placing Cerus Corporation (NASDAQ:CERS) Shares Under the Microscope - Post News (NASDAQ:CERS) www.kentuckypostnews.com - September 8 at 5:52 AM
	Cerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (NASDAQ:CERS) www.publicnow.com - September 7 at 9:20 AM
	Cerus Corporation (NASDAQ:CERS) Analyst Estimates - The Independent Republic (NASDAQ:CERS) theindependentrepublic.com - September 2 at 3:58 PM
	CERUS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (NASDAQ:CERS) biz.yahoo.com - September 1 at 12:38 PM
	Cerus Corp. breached its 50 day moving average in a Bearish Manner : CERS-US : September 1, 2016 (NASDAQ:CERS) www.capitalcube.com - September 1 at 12:38 PM
	Cerus to Present at the Baird 2016 Healthcare Conference on September 8, 2016 (NASDAQ:CERS) finance.yahoo.com - September 1 at 12:38 PM
	FDA To Screen All Donated Blood For The Zika Virus (NASDAQ:CERS) www.huffingtonpost.com - August 30 at 12:04 PM
	Cerus (CERS) Affirms Revised FDA Guidance with Respect to Zika Virus Testing (NASDAQ:CERS) www.streetinsider.com - August 30 at 12:04 PM
	FDA's New Recommendation for Universal Zika Risk Reduction of Blood Components Includes Use of Pathogen Reduction (NASDAQ:CERS) www.pharmiweb.com - August 30 at 12:04 PM
	Cerus INTERCEPT Blood System Among New Safety Measures Recommended By FDA - Benzinga (NASDAQ:CERS) www.benzinga.com - August 29 at 3:32 PM
	The Key Numbers To Watch From Cerus Corporation (NASDAQ:CERS)'s Earnings - The Voice Registrar (NASDAQ:CERS) voiceregistrar.com - August 29 at 3:32 PM
	Biotech Stocks To Put On Your Watch List: Cerus Corporation (NASDAQ:CERS), Array BioPharma Inc. (NASDAQ:ARRY) - The Voice Registrar (NASDAQ:CERS) voiceregistrar.com - August 29 at 3:32 PM
	Cerus INTERCEPT Blood System Among New Safety Measures Recommended By FDA (NASDAQ:CERS) feeds.benzinga.com - August 29 at 12:41 PM
	Cerus : FDA's New Recommendation for Universal Zika Risk Reduction of Blood Components Includes Use of Pathogen Reduction (NASDAQ:CERS) www.4-traders.com - August 29 at 8:54 AM
	FDA recommends Zika testing for all blood donated in U.S. (NASDAQ:CERS) www.reuters.com - August 28 at 8:51 AM
	Recent Insider Activity: Cerus Corporation (NASDAQ:CERS) - Post Registrar (NASDAQ:CERS) postregistrar.com - August 27 at 9:11 AM
	UPDATE 4-FDA recommends Zika testing for all blood donated in U.S. (NASDAQ:CERS) finance.yahoo.com - August 27 at 9:11 AM
	ETF’s with exposure to Cerus Corp. : August 26, 2016 (NASDAQ:CERS) www.capitalcube.com - August 26 at 11:59 AM
	CERUS CORP Financials (NASDAQ:CERS) finance.yahoo.com - August 16 at 4:12 PM
	ETF’s with exposure to Cerus Corp. : August 11, 2016 (NASDAQ:CERS) www.capitalcube.com - August 11 at 4:14 PM
	Buy the Dip During Dog Days (AKS, CERS) (NASDAQ:CERS) www.investopedia.com - August 10 at 4:12 PM
	Cerus Corp. :CERS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:CERS) www.capitalcube.com - August 10 at 4:12 PM
	Cerus Corporation (CERS) Drops 5.75% on August 08 - Equities.com (NASDAQ:CERS) www.equities.com - August 9 at 9:56 PM
	Cerus Corporation: Vivek Jayaraman Appointed as Cerus Corporation’s Chief Commercial Officer (NASDAQ:CERS) www.twst.com - August 9 at 12:23 PM
	Vivek JayaramanAppointed as Cerus Corporations Chief Commercial Officer (NASDAQ:CERS) www.cbs58.com - August 9 at 12:23 PM
	Vivek Jayaraman Appointed as Cerus Corporation’s Chief Commercial Officer (NASDAQ:CERS) www.publicnow.com - August 9 at 12:23 PM
	Edited Transcript of CERS earnings conference call or presentation 4-Aug-16 8:15pm GMT (NASDAQ:CERS) finance.yahoo.com - August 8 at 8:58 AM
	These Are Analyst Ratings Worth Watching: Cerus Corporation (NASDAQ:CERS), TherapeuticsMD Inc (NYSEMKT ... - Review Fortune (NASDAQ:CERS) reviewfortune.com - August 6 at 11:47 AM
	Zika Headlines Continue To Be Tailwinds For Cerus (NASDAQ:CERS) www.benzinga.com - August 5 at 4:11 PM
	CERUS CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:CERS) biz.yahoo.com - August 5 at 4:11 PM
	Cerus reports 2Q loss (NASDAQ:CERS) sg.finance.yahoo.com - August 4 at 9:52 PM
	Cerus Corporation Reports Second Quarter 2016 Results (NASDAQ:CERS) finance.yahoo.com - August 4 at 4:18 PM
	Cerus Corporation (CERS) Hits New 52-week High During August 01 Session - Equities.com (NASDAQ:CERS) www.equities.com - August 3 at 12:27 PM
	Biotechnology Stocks Under Review: Cerus Corporation (NASDAQ:CERS), Inovio Pharmaceuticals Inc (NASDAQ:INO) - Post Registrar (NASDAQ:CERS) postregistrar.com - August 2 at 4:15 PM
	Analyst's Report Preview: Cerus Corporation (NASDAQ:CERS) - The Voice Registrar (NASDAQ:CERS) voiceregistrar.com - August 2 at 8:56 AM
	HC Stocks Analysis: Cerus Corporation (NASDAQ:CERS) Anavex Life Sciences Corp. (NASDAQ:AVXL) - share market updates (press release) (NASDAQ:CERS) sharemarketupdates.com - August 1 at 8:59 AM
	Cerus (CERS) in Focus: Stock Moves 6% Higher in Session (NASDAQ:CERS) finance.yahoo.com - August 1 at 8:05 AM
	It's Earnings Time: What to Do with Cerus Corporation (NASDAQ ... - The Voice Registrar (NASDAQ:CERS) voiceregistrar.com - July 30 at 12:40 PM
	Cerus Corporation (CERS) is Trading Higher on Unusual Volume for July 28 - Equities.com (NASDAQ:CERS) www.equities.com - July 30 at 12:40 PM
	Cerus Corporation (CERS) Jumps 6.03% on July 29 - Equities.com (NASDAQ:CERS) www.equities.com - July 30 at 12:40 PM
	Cantor Weighs In on Cerus Corporation (CERS) as FDA Halted Blood Donations in Two FL Counties Due to Zika - Smarter Analyst (NASDAQ:CERS) www.smarteranalyst.com - July 29 at 9:37 PM
	Analysts Update on Stocks: Pfizer, Inc. (NYSE:PFE) , Cerus Corporation (NASDAQ:CERS) - Street Updates (NASDAQ:CERS) www.streetupdates.com - July 29 at 4:15 PM
	Investor Catching Stock: Cerus Corporation (NASDAQ:CERS) - News Oracle (NASDAQ:CERS) www.newsoracle.com - July 29 at 4:14 PM
	Friday's Zika Reports Explained: Winners And Losers (NASDAQ:CERS) finance.yahoo.com - July 29 at 2:46 PM